维力医疗：积极参与每一次集采 采取灵活的价格策略

Core Viewpoint - The company, Weili Medical, is actively participating in a collective procurement initiative led by the Chongqing Medical Insurance Bureau for ureteral stent medical consumables across 26 provinces, indicating a strategic move to enhance market presence and competitiveness [2]. Group 1 - The company’s subsidiary, Zhangjiagang Shagong Medical Device Technology Development Co., Ltd., ranked 7th in the first-year procurement demand for the collective procurement initiative, suggesting a strong position for potential selection in the A bidding unit [2]. - The current stage of the collective procurement is focused on product information submission, with pricing not yet initiated, making it difficult to predict the final awarded quantities [2]. - The company aims to adopt flexible pricing strategies in every collective procurement to maximize the chances of winning bids for all involved products, with the goal of rapidly increasing market coverage and share in the domestic market [2].